Shlevin Harold H.'s Form 4 filing
Galectin Therapeutics Inc (GALT) · filed Dec 16, 2025
- Accession no.
- 0001133416-25-000064
- Filed
- Dec 16, 2025
- Trade date
- Dec 12-15, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $177.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shlevin Harold H.CIK 0001557082 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | Common Stock | MOption exerciseAcquired | +19,793 | $4.16 | +$82,338.88 | 30,999 | Direct | |
| Dec 12, 2025 | Common Stock | SSaleDisposed | −19,793 | $6.27F2 | −$124,102.11 | 11,206 | Direct | |
| Dec 15, 2025 | Common Stok | MOption exerciseAcquired | +8,417 | $4.16 | +$35,014.72 | 19,623 | Direct | |
| Dec 15, 2025 | Common Stock | SSaleDisposed | −8,417 | $6.30F2 | −$53,027.1 | 11,206 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | Common Stock | MOption exerciseDisposed | −16,790 | $0.00 | $0 | 53,417 | Direct | |
| Dec 15, 2025 | Common Stock | MOption exerciseDisposed | −8,417 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The shares were sold in multiple transactions at prices ranging from $6.25 to $6.40. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Referenced by the price of 2 transactions in Table I.